JADE BIOSCIENCES INC (JBIO) Stock Overview
NASDAQ:JBIO - US0080642061 - Common Stock
JBIO Key Statistics, Chart & Performance
The current stock price of JBIO is 7.81 USD. In the past month the price increased by 6.15%.
JBIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.75 | 369.42B | ||
| AMGN | AMGEN INC | 12.84 | 150.79B | ||
| GILD | GILEAD SCIENCES INC | 14.95 | 143.55B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.28 | 101.09B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 59.97B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.17 | 58.85B | ||
| ARGX | ARGENX SE - ADR | 81.94 | 46.48B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.02 | 40.82B | ||
| INSM | INSMED INC | N/A | 30.88B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.97B | ||
| NTRA | NATERA INC | N/A | 22.96B | ||
| BIIB | BIOGEN INC | 8.89 | 20.86B |
Related stock screener links
About JBIO
Company Profile
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2021-06-30. The Company’s lead asset, JADE-001, is an investigational anti-A PRoliferation-Inducing Ligand (APRIL) monoclonal antibody for the treatment of Immunoglobulin A (IgA) nephropathy (IgAN), an autoimmune condition in which the kidney is damaged by pathogenic IgA containing immune complexes, leading to proteinuria and kidney function decline, and potentially progressing to end-stage kidney disease requiring dialysis or transplantation. Designed to block the APRIL protein, JADE-001 targets an underlying cause of IgAN, offering the potential to reduce pathogenic IgA levels, decrease proteinuria, and preserve kidney function over the long term. The Company’s pipeline also includes two undisclosed antibody discovery programs: JADE-002 and JADE-003, which are in preclinical development.
Company Info
JADE BIOSCIENCES INC
221 Crescent St., Building 23, Suite 105
Waltham MASSACHUSETTS US
Employees: 4
Phone: 17813123013
JADE BIOSCIENCES INC / JBIO FAQ
What is the stock price of JADE BIOSCIENCES INC today?
The current stock price of JBIO is 7.81 USD. The price increased by 0.51% in the last trading session.
What is the ticker symbol for JADE BIOSCIENCES INC stock?
The exchange symbol of JADE BIOSCIENCES INC is JBIO and it is listed on the Nasdaq exchange.
On which exchange is JBIO stock listed?
JBIO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for JADE BIOSCIENCES INC stock?
11 analysts have analysed JBIO and the average price target is 17.09 USD. This implies a price increase of 118.76% is expected in the next year compared to the current price of 7.81. Check the JADE BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is JADE BIOSCIENCES INC worth?
JADE BIOSCIENCES INC (JBIO) has a market capitalization of 254.84M USD. This makes JBIO a Micro Cap stock.
How many employees does JADE BIOSCIENCES INC have?
JADE BIOSCIENCES INC (JBIO) currently has 4 employees.
What are the support and resistance levels for JADE BIOSCIENCES INC (JBIO) stock?
JADE BIOSCIENCES INC (JBIO) has a support level at 6.89 and a resistance level at 8.24. Check the full technical report for a detailed analysis of JBIO support and resistance levels.
Should I buy JADE BIOSCIENCES INC (JBIO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of JBIO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of JBIO, evaluating the profitability, health, valuation and growth aspects
- JADE BIOSCIENCES INC (JBIO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- JADE BIOSCIENCES INC (JBIO) Sales and EPS estimates to see what analysts future expectations are.
- JADE BIOSCIENCES INC (JBIO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- JADE BIOSCIENCES INC (JBIO) Insider and Institutional Ownership to learn about the owners and their transactions.
- JADE BIOSCIENCES INC (JBIO) Stock Chart to make your own analysis
- JADE BIOSCIENCES INC (JBIO) Latest news and press-releases to stay up to date.
Does JADE BIOSCIENCES INC (JBIO) stock pay dividends?
JADE BIOSCIENCES INC (JBIO) has a dividend yield of 1081.08%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of JBIO dividend history, reliability and sustainability.
When does JADE BIOSCIENCES INC (JBIO) report earnings?
JADE BIOSCIENCES INC (JBIO) will report earnings on 2025-11-10, after the market close.
What is the Price/Earnings (PE) ratio of JADE BIOSCIENCES INC (JBIO)?
JADE BIOSCIENCES INC (JBIO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-30.26).
What is the Short Interest ratio of JADE BIOSCIENCES INC (JBIO) stock?
The outstanding short interest for JADE BIOSCIENCES INC (JBIO) is 6.27% of its float. Check the ownership tab for more information on the JBIO short interest.
JBIO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to JBIO.
JBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to JBIO. While JBIO has a great health rating, there are worries on its profitability.
JBIO Financial Highlights
Over the last trailing twelve months JBIO reported a non-GAAP Earnings per Share(EPS) of -30.26. The EPS increased by 72.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.15% | ||
| ROE | -27.94% | ||
| Debt/Equity | 0 |
JBIO Forecast & Estimates
11 analysts have analysed JBIO and the average price target is 17.09 USD. This implies a price increase of 118.76% is expected in the next year compared to the current price of 7.81.